Gemcitabine and cisplatin for inoperable and/or metastatic biliary tree carcinomas: A multicenter phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM)

Annals of Oncology

Volumn 17, Issue SUPPL. 7, 2006, Pages

  Giuliani, F ^a   Gebbia, Vittorio ^b,e   Maiello, E ^c   Borsellino, N ^d   Bajardi, E ^b   Colucci, G ^a  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c Casa Sollievo Della Sofferenza   (Italy)

^d Buccheri La Ferla Hospital   (Italy)

^e NONE   (Italy)

Author keywords

Biliary tree carcinoma; Chemotherapy; Cisplatin; Gemcitabine

Indexed keywords

CISPLATIN; DEXAMETHASONE; GEMCITABINE; SEROTONIN 3 ANTAGONIST;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT SURGERY; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER GROWTH; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FATALITY; DRUG FEVER; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; FLU LIKE SYNDROME; GALLBLADDER CARCINOMA; GASTROINTESTINAL TOXICITY; HUMAN; INFECTION; INOPERABLE CANCER; LIVER METASTASIS; LIVER TOXICITY; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MULTICENTER STUDY; NEUTROPENIA; PERITONEUM METASTASIS; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; STOMATITIS; SURVIVAL TIME; THROMBOCYTOPENIA; VOMITING;

EID: 33745616822     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdl956     Document Type: Article

References (30)

1. Pitt HA, Grochow LB, Abrams RA. Cancer of the biliary tree. In De Vita VT, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology, 5th edition. Philadelphia: Lippincott-Raven 1997; 1114-1128.
2. De Groen PC, Gores GJ, LaRusso NF et al. Biliary tract cancers. N Engl J Med 1999; 341: 1368-1378.
3. Gores GJ: CholCngiocarcinoma: current concepts and insights. Hepatology 2003; 5: 961-969.
4. Leonard GD, O'Reilly EM. Biliary tract cancers: Current concepts and controversies. Expert Opin Pharmacother 2005; 6: 211-223.
5. Benjamin IS. Surgical possibilities for bile duct cancer: Standard surgical treatment. Ann Oncol 1999; 10 (Suppl 4): S239-S242.
6. Rajagopalan V, Daines WP, Grossbard ML, Kozuch P. Gallbladder and biliary tract carcinoma: A comprehensive update, Part 1. Oncology (Huntingt) 2004; 18: 889-896.
7. Martin RF, Rossi RL. Multidisciplinary considerations for patients with cancer of pancreas or biliary tract. Surg Clin North Am 2000; 80: 709-728.
8. van Riel JMGH, van Greningen CJ, Pinedo HM et al. Current chemotherapeutic possibilities in pancreaticobiliary cancer. Ann Oncol 1999; 10 (Suppl 4): S157-S161.
9. Mani S, Sciortino D, Sanuels B et al. Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced biliary carcinama. Invest New Drugs 1999; 17: 97-101.
10. Jones DV, Lozano R, Hoque A et al. Phase II study of paclitaxel therapy for unresectable biliary carcinomas. J Clin Oncol 1996; 14: 2306-2310.
11. Okada S, Ishii H, Nose H et al. A phase II study of cisplatin in patients with biliary tract cancer. Oncology 1994; 51: 515-517.
12. Taal BG, Audisio RA, Bleiberg H et al. Phase II trial of mitomycin C in advanced gallbladder and biliary tree carcinoma. An EORTC Gastrointestinal Tract Cooperative Group Study. Ann Oncol 1993; 4: 607-609.
13. Gebbia V, Maiello E, Testa A et al. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose folinic acid and oral hydroxyurea on a weekly schedule. Cancer 1996; 78: 1300-1307.
14. Choi CW, Choi IK, Seo JH et al. Effects of 5-fluorouracil and leucovorin in the treatment of biliary tract adenocarcinomas. Am J Clin Oncol 2000; 23: 425-428.
15. Ducreux M, van Cutsem E, van Laethem JL et al. A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: Results of the 40955 EORTC trial. Eur J Cancer 2005, 41: 398-403.
16. Colucci G, Giuliani F, Gebbia V et al. Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: A prospective randomized phase III study of the Gruppo Oncologico dell' Italia Meridionale. Cancer 2002; 94: 902-910.
17. Gebbia V, Giuliani F, Maiello E et al. Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: Results of a multicenter phase II study. J Clin Oncol 2001; 19: 4089-4091.
18. Dingle BH, Rumble RB, Brouwers MC. The role of gemcitabine in the treatment of cholangiocarcinoma and gallbladder cancer: A systematic review. Can J Gastroenterol 2005; 19: 711-716.
19. Bergman AM, Ruiz van Haperen VWT, Veerman G et al. Synergistic interaction between Cisplatin and Gemcitabine in vitro. Clin Cancer Res 1996; 2: 521-530.
20. Miller AB, Hoogstraten B, Staquet M et al. Reporting results of cancer treatment. Cancer 1981; 47: 207-214.
21. Kaplan EI, Meier P: Non parametric estimation for incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
22. Malka D, Boige V, Dromain C et al. Biliary tract neoplasms: Update 2003. Curr Opin Oncol 2004; 16: 364-371.
23. van Riel JMGH, van Greningen CJ, Pinedo HM, Giaccone G. Current chemotherapeutic possibilities in pancreaticobiliary cancer. Ann Oncol 1999; 10 (Suppl 4): S157-S161.
24. Glimelius B, Hoffman K, Sjoden PO et al. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol 1996; 7: 593-600.
25. Malik IA, Aziz Z, Zaidi SH, Sethuraman G. Gemcitabine and cisplatin is a highly effective combination chemotherapy in patients with advanced cancer of the gallbladder. Am J Clin Oncol 2003; 26: 174-177.
26. Doval DC, Sekholm JS, Gupta SKL et al. A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall-bladder cancer. Br J Cancer 2004; 90: 1516-1520.
27. Thongprasert S, Napapan S, Charoentum C, Moonprakan S. Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma Ann Oncol 2005; 16: 279-281.
28. André T, Tournigand C, Rosmorduc O et al. Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: A GERCOR study. Ann Oncol 2004; 15: 1339-1343.
29. Kim ST, Park JO, Lee J et al. A phase II study of gemcitabine and cisplatin in advanced biliary tract cancer. Cancer 2006; 106: 1339-1346.
30. Oettle H, Arning M, Pelzer U et al. A phase II trial of gemcitabine in combination with 5-fluorouracil and folinic acid in patients with chemotherapy advanced pancreatic cancer. Ann Oncol 2000; 11: 1267-1272.